We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+47.43%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$540M
AUM Growth
+$30.8M
Cap. Flow
-$71M
Cap. Flow %
-13.15%
Top 10 Hldgs %
9.77%
Holding
405
New
161
Increased
21
Reduced
59
Closed
149

Top Sells

Rank Stock Value
1
VKTX icon
Viking Therapeutics
VKTX
+$5.66M
2
HROW icon
Harrow
HROW
+$5.57M
3
PI icon
Impinj
PI
+$5.06M
4
CECO icon
Ceco Environmental
CECO
+$4.79M
5
PARR icon
Par Pacific Holdings
PARR
+$4.38M

Sector Composition

Rank Sector Weight
1 Healthcare 26.89%
2 Technology 25.18%
3 Industrials 23.68%
4 Consumer Discretionary 11.94%
5 Consumer Staples 3.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUR icon
201
Aurora
AUR
$14.2B
$1.24M 0.23%
+421,559
New +$706K
ICFI icon
202
ICF International
ICFI
$1.56B
$1.24M 0.23%
+9,938
New +$1.15M
CLH icon
203
Clean Harbors
CLH
$16.4B
$1.23M 0.23%
7,492
-1,429
-16% -$209K
DFH icon
204
Dream Finders Homes
DFH
$1.3B
$1.2M 0.22%
+48,924
New +$881K
PGTI
205
DELISTED
PGT, Inc.
PGTI
$1.2M 0.22%
+41,147
New +$1.08M
GHM icon
206
Graham Corp
GHM
$1.23B
$1.2M 0.22%
90,162
-37,531
-29% -$473K
SOFI icon
207
SoFi Technologies
SOFI
$24.1B
$1.2M 0.22%
+143,520
New +$936K
ATOM icon
208
Atomera
ATOM
$219M
$1.18M 0.22%
+134,773
New +$1.06M
SONM icon
209
DNA X Inc
SONM
$6.07M
$1.17M 0.22%
+5,671
New +$1.11M
NUVL
210
DELISTED
Nuvalent
NUVL
$1.17M 0.22%
27,754
DO
211
DELISTED
Diamond Offshore Drilling, Inc.
DO
$1.17M 0.22%
82,111
-5,966
-7% -$70.6K
DMAC icon
212
DiaMedica Therapeutics
DMAC
$352M
$1.17M 0.22%
+270,419
New +$657K
WT icon
213
WisdomTree
WT
$3.21B
$1.16M 0.22%
+169,818
New +$1.14M
HYPR icon
214
Hyperfine
HYPR
$101M
$1.16M 0.22%
+541,065
New +$882K
ASRT
215
DELISTED
Assertio
ASRT
$1.16M 0.22%
14,289
-34,583
-71% -$3.21M
IESC icon
216
IES Holdings
IESC
$15.1B
$1.15M 0.21%
+20,185
New +$965K
PACB icon
217
Pacific Biosciences
PACB
$447M
$1.14M 0.21%
85,761
UPBD icon
218
Upbound Group
UPBD
$1.2B
$1.13M 0.21%
+36,173
New +$1.06M
HBIO icon
219
Harvard Bioscience
HBIO
$28.5M
$1.13M 0.21%
20,499
-14,056
-41% -$771K
ALGT icon
220
Allegiant Air
ALGT
$2.82B
$1.11M 0.21%
+8,777
New +$918K
CLMB icon
221
Climb Global Solutions
CLMB
$500M
$1.11M 0.21%
92,492
-47,848
-34% -$583K
ATEC icon
222
Alphatec Holdings
ATEC
$1.59B
$1.11M 0.2%
61,485
-59,220
-49% -$922K
XFOR icon
223
X4 Pharmaceuticals
XFOR
$386M
$1.1M 0.2%
+18,927
New +$973K
ERII icon
224
Energy Recovery
ERII
$470M
$1.1M 0.2%
+39,197
New +$977K
NVRI icon
225
Enviri
NVRI
$671M
$1.09M 0.2%
+110,672
New +$912K

Similar funds

EAM Investors's Q2 2023 Portfolio in Review

As of Q2 2023, EAM Investors held 405 positions worth $540M, up 6% from $509M the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

EAM Investors withdrew a net $71M in Q2 2023, closing 149 positions and reducing 59 holdings. Its most notable exit was Viking Therapeutics, an estimated $5.66M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

Against the trend, EAM Investors opened a new position in Applied Digital worth $7.24M.

  • EAM Investors's largest Q2 2023 buy was Applied Digital: 774,423 shares worth $7.24M.
  • EAM Investors added most to Arlo Technologies in Q2 2023, an estimated $2.35M increase.
  • EAM Investors's biggest Q2 2023 reduction was Harrow, cutting an estimated $5.57M.
  • EAM Investors fully exited Viking Therapeutics in Q2 2023, selling an estimated $5.66M.
  • EAM Investors's ten largest holdings make up 9.8% of its $540M portfolio in Q2 2023.
  • EAM Investors opened 161 new positions and closed 149 in Q2 2023.
  • EAM Investors's portfolio value rose 6% quarter-over-quarter to $540M.

Based on EAM Investors's 13F filing for Q2 2023, filed 11 Aug 2023.